Literature DB >> 29369398

Neutrophil hyperactivation correlates with Alzheimer's disease progression.

Yuan Dong1, Julien Lagarde2,3, Laura Xicota4, Hélène Corne2, Yannick Chantran1, Thomas Chaigneau1, Bruno Crestani5, Michel Bottlaender3,6, Marie-Claude Potier4, Pierre Aucouturier1, Guillaume Dorothée1, Marie Sarazin2,3, Carole Elbim1.   

Abstract

OBJECTIVE: Recent studies have underlined the effect of systemic inflammation on the pathophysiology of Alzheimer's disease (AD). Neutrophils are key components of early innate immunity and contribute to uncontrolled systemic inflammation if not tightly regulated. The aim of our study was to fully characterize human circulating neutrophils at different disease stages in AD.
METHODS: We analyzed neutrophil phenotypes and functions in 42 patients with AD (16 with mild cognitive impairment and 26 with dementia), and compared them to 22 age-matched healthy subjects. This study was performed directly in whole blood to avoid issues with data interpretation related to cell isolation procedures.
RESULTS: Blood samples from AD patients with dementia revealed neutrophil hyperactivation associated with increased reactive oxygen species production and increased levels of intravascular neutrophil extravascular traps. The homeostasis of circulating neutrophils in these patients also changed: The ratio between the harmful hyperreactive CXCR4high /CD62Llow senescent and the CD16bright /CD62Ldim immunosuppressive neutrophil subsets rose in the later stage of the disease. These abnormalities were greater in fast-decliner than in slow-decliner patients.
INTERPRETATION: Our results indicate that the inflammatory properties of circulating neutrophils shift as the percentage of aged neutrophils expands in patients with AD-changes that may play an instrumental role in establishing systemic chronic inflammation. Most important, our data strongly suggest that the neutrophil phenotype may be associated with the rate of cognitive decline and may thus constitute an innovative and prognostic blood biomarker in patients with AD. Ann Neurol 2018;83:387-405.
© 2018 American Neurological Association.

Entities:  

Mesh:

Year:  2018        PMID: 29369398     DOI: 10.1002/ana.25159

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Age-dependent cognitive impairment, hydrocephalus and leukocyte infiltration in transgenic mice with endothelial expression of human EPHX2.

Authors:  Catherine M Davis; Wenri H Zhang; Thierno M Bah; Natalie E Roese; Elyse M Allen; Philberta Leung; Sydney J Boutros; Tessa Marzulla; Esha Patel; Xiao Nie; Farah N Alkayed; Justin H Huang; Michael A Jensen; Jacob Raber; Martin M Pike; Nabil J Alkayed
Journal:  NPJ Aging       Date:  2022-07-05

Review 2.  Unveiling Leukocyte Extracellular Traps in Inflammatory Responses of the Central Nervous System.

Authors:  Francesca Colciaghi; Massimo Costanza
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

3.  Data-driven health deficit assessment improves a frailty index's prediction of current cognitive status and future conversion to dementia: results from ADNI.

Authors:  Andreas Engvig; Luigi A Maglanoc; Nhat Trung Doan; Lars T Westlye
Journal:  Geroscience       Date:  2022-10-19       Impact factor: 7.581

4.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04

5.  Harmful neutrophil subsets in patients with ischemic stroke: Association with disease severity.

Authors:  David Weisenburger-Lile; Yuan Dong; Marion Yger; Gaëlle Weisenburger; Giulia Frasca Polara; Thomas Chaigneau; Riccardo Zapata Ochoa; Beatrice Marro; Bertrand Lapergue; Sonia Alamowitch; Carole Elbim
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-05-15

6.  Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer's Disease.

Authors:  Rotem Volkman; Tali Ben-Zur; Anat Kahana; Ben Zion Garty; Daniel Offen
Journal:  Front Neurosci       Date:  2019-09-24       Impact factor: 4.677

7.  Sulfonated Nonsaccharide Heparin Mimetics Are Potent and Noncompetitive Inhibitors of Human Neutrophil Elastase.

Authors:  Rami A Al-Horani; Kholoud F Aliter; Srabani Kar; Madhusoodanan Mottamal
Journal:  ACS Omega       Date:  2021-05-03

Review 8.  Necroptosis: A Novel Pathway in Neuroinflammation.

Authors:  Ziyu Yu; Nan Jiang; Wenru Su; Yehong Zhuo
Journal:  Front Pharmacol       Date:  2021-07-12       Impact factor: 5.810

9.  Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis.

Authors:  Daichi Shigemizu; Taiki Mori; Shintaro Akiyama; Sayuri Higaki; Hiroshi Watanabe; Takashi Sakurai; Shumpei Niida; Kouichi Ozaki
Journal:  Alzheimers Res Ther       Date:  2020-07-16       Impact factor: 6.982

10.  A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease.

Authors:  Kritleen K Bawa; Saffire H Krance; Nathan Herrmann; Hugo Cogo-Moreira; Michael Ouk; Di Yu; Che-Yuan Wu; Sandra E Black; Krista L Lanctôt; Walter Swardfager
Journal:  J Neuroinflammation       Date:  2020-03-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.